Loading company…
Zhongke Shuaitian Pharmaceutical develops drug candidates for cancer treatment.
Zhongke Shuaitian Pharmaceutical researches small molecule precursor drugs and antibody-coupled drugs for anti-tumor treatment. Its drug candidates are designed to improve therapeutic targeting and can be used in radiotherapy and chemotherapy combinations. Established in 2021 and based in Shenzhen, China, the company raised strategic investment from Cowin Capital in June 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in